Cryotherapy for partial gland ablation of prostate cancer: Oncologic and safety outcomes

BACKGROUND: Partial gland ablation (PGA) is a new option for treatment of prostate cancer (PCa). Cryotherapy, an early method of PGA, has had favorable evaluations, but few studies have employed a strict protocol using biopsy endpoints in men with clinically significant prostate cancer (csPCa). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Aker, Mamdouh N., Brisbane, Wayne G., Kwan, Lorna, Gonzalez, Samantha, Priester, Alan M., Kinnaird, Adam, Delfin, Merdie K., Felker, Ely, Sisk, Anthony E., Kuppermann, David, Marks, Leonard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166973/
https://www.ncbi.nlm.nih.gov/pubmed/36775929
http://dx.doi.org/10.1002/cam4.5692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166973/
https://www.ncbi.nlm.nih.gov/pubmed/36775929
http://dx.doi.org/10.1002/cam4.5692

Ejemplares similares